Jaguar Health Announces Record Date for Special Stock Dividend

Jaguar Health, Inc. (NASDAQ:JAGX) has confirmed October 13, 2026, as the Record Date for its Special Stock Dividend. This initiative targets holders of the company's Common Stock and specific warrants. The Special Stock Dividend consists of Series R Convertible Preferred Stock, set to be paid on October 15, 2026. Shareholders eligible on the Record Date will receive these shares, which convert to Common Stock on November 2, 2026.

CEO Lisa Conte emphasized the Special Stock Dividend aims to reward existing stockholders and mitigate dilution risks while exploring strategic options. Jaguar Health focuses on the global development of oral crofelemer, especially for rare intestinal diseases like MVID and SBS-IF. The company plans a New Drug Application for MVID by mid-2027, supported by ongoing clinical milestones.